Search

Your search keyword '"Bronchodilator Agents chemistry"' showing total 617 results

Search Constraints

Start Over You searched for: Descriptor "Bronchodilator Agents chemistry" Remove constraint Descriptor: "Bronchodilator Agents chemistry"
Sorry, I don't understand your search. ×
617 results on '"Bronchodilator Agents chemistry"'

Search Results

1. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.

2. Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques.

Catalog

Books, media, physical & digital resources

3. Greenhouse Gas Emissions and Costs of Inhaler Devices in the US.

4. Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles.

5. Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug dissolution and permeability.

6. Influence of design parameters on sustained drug release properties of 3D-printed theophylline tablets.

7. Nanoscale colocalized thermal and chemical mapping of pharmaceutical powder aerosols.

8. Determination of Aminophylline in Human Serum Using Hydrogel Microspheres for Coupled Surface-Enhanced Raman Spectroscopy (SERS) and Solid-Phase Extraction.

9. Preparation, Optimization and In Vitro Characterization of Fluticasoneloaded Mixed Micelles Based on Stearic Acid-g-chitosan as a Pulmonary Delivery System.

10. Detection of Asthma Inhaler Use via Terahertz Spectroscopy.

11. Technical features of vaping drug delivery system for bronchodilator delivery.

12. The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms.

13. YG-1 Extract Improves Acute Pulmonary Inflammation by Inducing Bronchodilation and Inhibiting Inflammatory Cytokines.

14. Allergic Contact Dermatitis to the Ethylenediamine Component of Aminophylline in a Neck Cream.

15. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.

16. 4-(3H)-quinazolinones N-3 substituted with a five membered heterocycle: A promising scaffold towards bioactive molecules.

17. Large-volume, preservative-free albuterol concentrate.

18. The Relaxant Effect of Plantago Major on Rat Tracheal Smooth Muscles and Its Possible Mechanisms.

19. Sanguinarine Rapidly Relaxes Rat Airway Smooth Muscle Cells Dependent on TAS2R Signaling.

20. Bronchospasmolytic activity and adenosine receptor binding of some newer 1,3-dipropyl-8-phenyl substituted xanthine derivatives.

21. Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma.

22. A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation.

23. Medication Tracking: Design and Fabrication of a Dry Powder Inhaler with Integrated Acoustic Element by 3D Printing.

24. Delivered Lung Dose and Aerodynamic Particle Size Distribution of Salbutamol Pressurized Metered Dose Inhaler After Living Under Patients' Realistic Retention Environments.

25. Association of human serum paraoxonase-1 with some respiratory drugs.

26. Impact of drug particle shape on permeability and cellular uptake in the lung.

27. Stability of Polymer Coatings on Nebulizer Membranes During Aerosol Generation.

28. Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.

29. Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity.

30. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective.

31. Drug distribution transients in solution and suspension-based pressurised metered dose inhaler sprays.

32. Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).

33. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.

34. Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide.

35. Histamine (H1) Receptors, Cyclooxygenase Pathway and Nitric Oxide Formation Involved in Rat Tracheal Smooth Muscle Relaxant Effect of Berberine.

36. Effect of USP Induction Ports, Glass Sampling Apparatus, and Inhaler Device Resistance on Aerodynamic Patterns of Fluticasone Propionate-Loaded Engineered Mannitol Microparticles.

37. The impact of patients' real-life environmental temperature and humidity use conditions of tiotropium dry powder inhaler on its aerosol emission characteristics.

38. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.

39. Effective nebulization of interferon-γ using a novel vibrating mesh.

40. Design of Inhalable Solid Dosage Forms of Budesonide and Theophylline for Pulmonary Combination Therapy.

41. Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler.

42. Effect of Nebulizer Location and Spontaneous Breathing on Aerosol Delivery During Airway Pressure Release Ventilation in Bench Testing.

43. Fabrication of Hierarchical Polymeric Thin Films by Spin Coating Toward Production of Amorphous Solid Dispersion for Buccal Drug Delivery System: Preparation, Characterization, and In Vitro Release Investigations.

44. Spectroscopic and computational insights into theophylline/β-cyclodextrin complexation: inclusion accomplished by diverse methods.

45. Interaction of DNA and mononucleotides with theophylline investigated using electrochemical biosensors and biosensing.

46. Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast.

47. New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology.

48. Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β 2 -adrenoceptor agonists.

49. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose.

50. 1064 nm Dispersive Raman Microspectroscopy and Optical Trapping of Pharmaceutical Aerosols.